Oxford Nanopore Technologies plc

("Oxford Nanopore" or the "Company")

Oxford Nanopore to host an investor event and participate in upcoming investor conferences in November

16 October 2025

Oxford Nanopore Technologies plc (LSE: ONT), the company delivering a new generation of molecular sensing technology based on nanopores, today announces that it will host an investor event on 14 November 2025. At the event management will present on the topic of Oxford Nanopore's commercial strategy, providing greater insight on the attractive markets served by the Company and the opportunities for growth. Details of the event are as follows:

·      Oxford Nanopore Investor Event

Format: Virtual presentation and Q&A

Date: Friday, 14 November

Presentation time: 9:00am GMT (4:00am EST)

In addition, the Company will be participating in the following investor conferences in November:

·      J.P. Morgan UK Leaders Conference, London

Format: One-on-one and group investor meetings

Date: Tuesday, 18 November

·      Jefferies Global Healthcare Conference, London

Format: Presentation and one-on-one and group investor meetings

Date: Wednesday, 19 November

Presentation time: 11:30am GMT (6:30am EST)

Presentations from the investor event and investor conferences will be webcast live and can be accessed via the Investor Relations section of Oxford Nanopore's website at: https://nanoporetech.com/about-us/investors/reports. Replays will be available following the events via the same link.

-ENDS-

For further information, please contact:

Oxford Nanopore Technologies plc

Investors:        [email protected]

Media:             [email protected]

Teneo (communications adviser to the Company)

Tom Murray, Jo Blackshaw

+44 (0) 20 7353 4200

[email protected]

About Oxford Nanopore Technologies plc:

Oxford Nanopore Technologies' goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.  Oxford Nanopore's technology also has the potential to provide broad, high impact, rapid insights in a number of areas including healthcare, food and agriculture.

For more information please visit: www.nanoporetech.com